McCulloch Kevin bought XERS

March 12, 2026 · Form 4 insider transaction

McCulloch Kevin bought 4 shares of Xeris Biopharma Holdings, Inc. at $3.94 per share, a transaction worth $15.76. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
4
Price
$3.94
Total value
$15.76
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after1,777,725
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR